Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/20801
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adenine/administration & dosage/analogs & derivatives/therapeutic use,Adolescent,Adult,Aged,Antiviral Agents/administration & dosage/therapeutic use,Colitis, Ulcerative/complications/epidemiology,Crohn Disease/complications/epidemiology,Drug Therapy, Combination,Female,Greece/epidemiology,Hepatitis B/*complications/drug therapy/epidemiology,Hepatitis C/*complications/drug therapy/epidemiology,Humans,Inflammatory Bowel Diseases/*complications/epidemiology,Interferon-alpha/administration & dosage/therapeutic use,Lamivudine/administration & dosage/therapeutic use,Male,Middle Aged,Phosphonic Acids/administration & dosage/therapeutic use,Prevalence,Retrospective Studies,Ribavirin/administration & dosage/therapeutic use,Treatment Outcome
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/20801
ISSN: 1876-4479
Link: http://www.ncbi.nlm.nih.gov/pubmed/21122543
http://ac.els-cdn.com/S1873994610000462/1-s2.0-S1873994610000462-main.pdf?_tid=1650b68f06de7294d70bb01da4b5d98f&acdnat=1333962285_296b20186fa7e86218dee85625b8c296
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Katsanos-2010-Inflammatory bowel d.pdf297.9 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons